Fosun Health Thoracic Cancer Treatment Center mainly diagnoses and treats lung cancer, esophageal cancer, mediastinal tumors and pleural-related tumors, and provides multidisciplinary diagnosis and treatment relying on thoracic surgery, respiratory medicine, medical oncology, radiotherapy, imaging, pathology and rehabilitation. For pulmonary nodules or suspected chest tumors, the team will combine CT and other imaging, pathological examination, staging and pulmonary function assessment to clarify the nature of the disease and treatment goals.
For operable patients, the center can perform thoracoscopic or da Vinci robot-assisted lung cancer, esophageal cancer and mediastinal tumor surgery according to the indications, and pay attention to lymph node assessment, perioperative respiratory management and rapid recovery. Whether to perform surgery and the extent of resection need to be judged based on the location, stage, lung function and overall condition of the patient.
For patients who need radiotherapy, the center can rely on the M6 CyberKnife and VitalBeam platform to carry out image-guided, intensity-modulated or stereotactic radiotherapy. For lung lesions that move with breathing, the range of motion will be assessed before treatment and corresponding management methods will be selected; at the same time, the impact on important organs such as the normal lungs, heart, esophagus, and spinal cord will be controlled. Local treatment also needs to be reasonably connected with chemotherapy, targeted or immunotherapy.
The center also pays attention to problems such as cough, shortness of breath, hemoptysis, pleural effusion, pain and nutritional decline, and carries out breathing training, lung function management and recurrence follow-up before and after treatment. Through re-evaluation of key nodes, we can promptly judge the response after surgery, radiotherapy or drug treatment and adjust the follow-up plan.
Common treatment pathways for chest tumors
1. Lung tumors: distinguish between small cell lung cancer, non-small cell lung cancer and lung metastases. Early-stage non-small cell lung cancer usually gives priority to evaluation for surgery, and stereotactic radiotherapy can be selected for those who cannot be operated. Patients with local progression often require a combination of chemoradiotherapy and immunotherapy. Small cell lung cancer and metastatic lung cancer are mainly treated with systemic treatment, and radiotherapy to the chest or metastases is evaluated based on the scope of the disease.
2. Mediastinal and thymic tumors: Obtain pathological diagnosis and clarify the scope through surgery, and perform postoperative radiotherapy if necessary. The team will determine the sequence of surgery, radiotherapy, and drug treatment based on the pathological type, invasion of the capsule or adjacent structures, resection margins, and lymph node status.
3. Chest wall tumors and pleural tumors: surgery is the main method, or radiotherapy after pathology is obtained. The actual treatment needs to be determined based on the tumor source, possibility of resection, lung function, and pleural dissemination. Some patients also require reconstruction, systemic treatment, or symptom control.
4. Esophageal cancer and cardia cancer: early surgery, preoperative treatment for locally advanced stage or radical chemoradiotherapy. The thoracic surgery, gastrointestinal endoscopy, radiotherapy and medical oncology teams will choose minimally invasive surgery or comprehensive treatment based on the location, stage and nutritional status of the tumor.
